Revenue: $2.6 billion, up 5% year-over-year. Surgical Franchise Revenue: $1.4 billion, up 5% year-over-year. Implantable Sales: $432 million, up 2% year-over-year. Consumables Sales: $745 million, up ...
Alcon Inc. (NYSE:ALC) ranks among the best medical stocks to buy according to analysts. On July 10, Stifel reaffirmed its Buy rating for Alcon Inc. (NYSE:ALC) with a $100 price rating. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback